Keywords: dr, reddy, sees, full-year, sales, climb, india
Dr Reddy's sees full-year sales climb 11%
Article | 07 June 2004
India's Dr Reddy's Laboratories has posted revenues for the full year ending March 31 of 20 billion rupees ($442 million), marking solid 11% growth ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
